Kirthana “Kira” Beaulac is a clinical pharmacist at Tufts Medical Center. She received her PharmD at Massachusetts College of Pharmacy and completed post-doctoral training at Baystate Medical Center in Springfield, MA and Hartford Hospital in Hartford, CT. She is a Board-Certified Infectious Diseases Pharmacist and serves as the co-director of the Antimicrobial Management Team at Tufts Medical Center, which has been recognized as an Antibiotic Stewardship Center of Excellence. She holds the title of Assistant Professor of Medicine at Tufts University School of Medicine, and serves as a preceptor and mentor for pharmacy students at Northeastern University and PA students at Tufts University. Her research interests are in optimizing antibiotic choice and duration, and plans to bring her expertise and unique perspective to a multi-disciplinary approach to the treatment of COVID-19.

As President and CEO of the Massachusetts Biotechnology Council, Bob’s mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Over the last decade, Bob has truly become a champion for patients by ensuring innovative companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them. Bob has spent his career in both the public and private sectors. Before joining MassBio, he served as the Undersecretary of Economic Development within Governor Deval Patrick's administration, where he prioritized both healthcare and economic development issues and was a strong advocate for the life sciences industry in Massachusetts. Prior to that, he was elected as State Representative to the 11th Norfolk district for three terms. Bob has also held senior executive positions in the environmental services, capital management and venture capital industries. He brings passion and energy to all of his endeavors.

Dr. Harry P. Selker is Dean of Tufts Clinical and Translational Science Institute (CTSI) and Executive Director of the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. As Dean, he provides leadership for programs and infrastructure that support clinical and translational research at the Tufts University schools and affiliated hospitals, and other academic, community-based, and industry CTSI partners. He practices medicine at Tufts Medical Center. Dr. Selker‘s research focuses on the development of treatment strategies, decision aids, and systems aimed at improving medical care. He is known for his studies of the factors influencing emergency cardiac care and for development of "clinical predictive instruments," mathematical models that are used as decision aids. They provide emergency physicians and paramedics with predictions for their patients’ likely cardiac diagnoses and outcomes for real-time use in clinical care. This has included conduct of multiple large national clinical effectiveness trials that have demonstrated better treatment and clinical outcomes for patients with acute coronary syndromes. Additionally, Dr. Selker has done research to advance clinical study design, execution, issues around informed consent, data analysis, mathematical predictive modeling of medical outcomes, and comparative effectiveness research. Dr. Selker has contributed to health services and health policy research, with a focus on translational research that impacts public health. He has provided advice about healthcare delivery and medical research to policymakers, including the House and Senate authors of the Affordable Care Act. Dr. Selker has served as President of the Society of General Internal Medicine, the Society for Clinical and Translational Science, the Association for Clinical Research Training, and the Association for Clinical and Translational Science, and is currently Chair of the Clinical Research Forum.